Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (78) clinical trials

Over 5 million Americans are living with Alzheimer’s. That means millions of families are learning how to cope with this disease. If you or a loved one has been diagnosed with mild to moderate Alzheimer’s, you may be interested in this research study. Clinical Research Associates in Nashville, TN is ...

Phase

Patient Inclusion Criteria: Ages: over 60 Male/Female 18 week long Clinical Trial Patient may not be full time permanent resident of nursing home Clinical diagnosis of probable AD with supportive brain imaging documentation Have existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 90 week Long Clinical Trial MMSE score 22-30 Positive amyloid load as indicated by PET assessment Age between 50 and 90 years, inclusive MMSE score equal to or greater than 22, and equal to or less than 30, at Screening and Baseline BMI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 12 Month Long Clinical Trial MMSE score 14-20 Adult patients, 50-90 years of age inclusive at time of screening Probable Alzheimer disease, based on the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)/Alzheimer's Disease and Related Disorders Association (ADRDA) and DSM-IV-TR ...

Phase

Alzheimer's disease is the most common neurodegenerative disorder and its prevalence steeply increases. The small number of effective treatments for Alzheimer's disease highlights a need for further research into novel therapeutic possibilities. Glutamate-mediated excitotoxicity in neuropsychiatric disorders and in particular in Alzheimer's disease has been shown to cause significant cerebral ...

Phase

This is a multicenter, multinational study that be conducted to test the safety and effectiveness of an investigational medication against placebo ( a substance that looks like the study drug but does not contain the active ingredient) in patients with memory loss due to mild cognitive impairment or mild Alzheimer's ...

Phase

Are you or someone you care for experiencing memory loss possibly due to Alzheimer's disease?

Phase

Eli Lilly and Company (Lilly) is developing LY3202626, a synthetic small molecule which is a potent inhibitor of β-site amyloid precursor protein (APP)-cleaving enzyme [BACE]1, for the treatment of Alzheimer’s disease (AD). It is hypothesized that inhibition of BACE1 may slow or inhibit the progression of AD. Study I7X-MC-LLCF (LLCF), ...

Phase

Researchers are studying a drug called BAN2401 in people who have early Alzheimer's disease . People with Alzheimer's disease have a buildup of abnormal protein, known as amyloid, in their brains. BAN2401 may reduce the amount of this abnormal protein. The study drug will be given through injection into a ...

Phase

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Phase